Better Buy: Eli Lilly vs. Viking Therapeutics

Comparing Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of Viking by market cap and boasts a long list of approved medicines and an impressive track record of…#comparingelililly #lly #elililly #type2 #glp1 #fda #jardiance #omvoh #jaypirca #vk2809
Source: Reuters: Health - Category: Consumer Health News Source Type: news